Skip to main content
840 search results for:

Blinatumomab 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-04-2024 | Blinatumomab | News

    Blinatumomab

    Seizure and lack of efficacy
  2. 01-04-2024 | Blinatumomab | News

    Blinatumomab

    Bone marrow necrosis
  3. 01-03-2024 | Blinatumomab | News

    Blinatumomab/inotuzumab-ozogamicin

    Various toxicities, lack of efficay and drug resistance
  4. 16-03-2024 | Blinatumomab | Letter

    Isolated salivary gland extramedullary relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during blinatumomab treatment

  5. 01-03-2024 | Blinatumomab | News

    Blinatumomab

    Immune effector cell-associated neurotoxicity syndrome
  6. 01-03-2024 | Blinatumomab | News

    Blinatumomab

    Cytokine release syndrome
  7. 01-03-2024 | Blinatumomab | News

    Blinatumomab

    Neurotoxicity syndrome following off-label use
  8. Open Access 25-04-2024 | Blinatumomab | Online First

    Real-world evidence on treatment pattern, effectiveness, and safety of blinatumomab in Chinese patients with B-cell acute lymphoblastic leukemia

    Blinatumomab is efficacious in patients with B-cell acute lymphoblastic leukemia (B-ALL), yet limited real-world data exists in this context. This retrospective study provided real-world data on the treatment pattern, effectiveness, and safety of …

  9. 01-03-2024 | Blinatumomab | News

    Blinatumomab

    Immune effector cell-associated neurotoxicity syndrome
  10. 01-02-2024 | Blinatumomab | News

    Blinatumomab

    Lack of efficacy
  11. 13-04-2024 | Blinatumomab | Online First

    Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study

    Blinatumomab is a bispecific T-cell engager approved for relapsed/refractory and minimal residual disease positive B-cell Acute Lymphoblastic Leukemia. We conducted a retrospective study evaluating the outcome of Blinatumomab. The impact of …

  12. 17-02-2024 | Endocarditis | Letter

    Effectiveness and safety of blinatumomab for pediatric B cell acute lymphoblastic leukemia with Loeffler’s endocarditis

  13. Open Access 17-02-2024 | Blinatumomab | OriginalPaper

    Successful treatment of a B/T MPAL patient by chemo-free treatment with venetoclax, azacitidine, and blinatumomab

    B/T mixed phenotype acute leukemia (MPAL), which represents only 2–3% of all MPAL cases, is classified as a high-risk leukemia subtype. Adults diagnosed with B/T MPAL have a notably low 3-year survival rate, estimated at 20–40%. The rarity and …

  14. 07-12-2023 | Blinatumomab | ReviewPaper

    Blinatumomab in Practice

    Acute lymphoblastic leukemia (ALL) is a hematologic neoplasm that arises from immature T or B lymphocytes with approximately 6000 new cases diagnosed annually in the USA [ 1 ]. This is the most common childhood leukemia with up to 60% of cases …

  15. 01-01-2024 | Blinatumomab | News

    Blinatumomab

    Lack of efficacy: case report
  16. Open Access 01-12-2024 | Blinatumomab | Letter

    Life-threatening complications and intensive care unit management in patients treated with blinatumomab for B-cell acute lymphoblastic leukemia

  17. 01-12-2023 | Blinatumomab | News

    Blinatumomab

    Cytokine release syndrome
  18. 01-12-2023 | Blinatumomab | News

    Blinatumomab

    Multiple toxicities: 11 case reports
  19. 01-12-2023 | Blinatumomab | News

    Blinatumomab/Inotuzumab-ozogamicin

    Neurological side effects, drug intolerance and cardiac side effects
  20. 01-12-2023 | Blinatumomab | News

    Blinatumomab/ciclosporin

    Haemorrhagic cystitis and lack of efficacy: case report

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.